Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management.

Saved in:
Bibliographic Details
Title: Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management.
Authors: Gallagher KE; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Awori JO; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Knoll MD; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Rhodes J; Global Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand., Higdon MM; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Hammitt LL; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Prosperi C; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Baggett HC; Global Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.; Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Brooks WA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka and Matlab, Bangladesh., Fancourt N; Menzies School of Health Research, Charles Darwin University, Darwin, Australia., Feikin DR; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Howie SRC; Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Basse, The Gambia.; Department of Paediatrics, University of Auckland, Auckland, New Zealand., Kotloff KL; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Tapia MD; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Levine OS; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Madhi SA; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Murdoch DR; Department of Pathology and Biomedical Sciences, University of Otago, Christchurch, New Zealand.; Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand., O'Brien KL; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Thea DM; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America., Baillie VL; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Ebruke BE; Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Basse, The Gambia., Kamau A; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Moore DP; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.; Department of Paediatrics & Child Health, Chris Hani Baragwanath Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa., Mwananyanda L; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America.; Right to Care-Zambia, Lusaka, Zambia., Olutunde EO; Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Basse, The Gambia., Seidenberg P; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America., Sow SO; Centre pour le Développement des Vaccins (CVD-Mali), Bamako, Mali., Thamthitiwat S; Global Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand., Scott JAG; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.
Corporate Authors: PERCH Study Group
Source: PloS one [PLoS One] 2024 Mar 11; Vol. 19 (3), pp. e0297159. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0297159